Beyond Diabetes and Weight Loss The Growing Demand for GLP-1 Therapies In 2023, over 174,000 people in the United States were prescribed GLP-1RAs, a rise of over 700% from 2019, when about 21,000 individuals were prescribed this medication
Bitte beachten Sie, dass dabei Daten an Drittanbieter weitergegeben werden.
PlexusDx patients working with their care team often report these digestive symptoms resolve faster when they follow personalized meal timing and hydration protocols tailored to their injection day
It is contraindicated in patients with medical records of hyperthyroidism, glaucoma, or cardiovascular disease
Is consultation required
Understanding these cardiovascular effects is essential for safe prescribing and monitoring, particularly in patients with baseline hypotension or those taking antihypertensive medications